With cardiovascular diseases remaining prominent, lipid management has seen significant advancements.
New therapies, such as PCSK9 inhibitors and bempedoic acid, have been introduced, providing more treatment options.
Guidelines have been updated to include LDL-C levels, risk assessment, and the use of non-statin therapies.
Personalized medicine is gaining momentum, with genetic testing aiding in identifying patients who may benefit from specific treatments.
These advancements offer healthcare professionals a broader, more effective toolkit for managing patients' lipid levels.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation